Bressler, Adam M.
Hassoun, Ali A.
Saravolatz, Louis D.
Ravenna, Valerie
Barnes, Chris N.
Castaneda-Ruiz, Bibiana
Funding for this research was provided by:
Theravance Biopharma R&D, Inc.
Article History
First Online: 6 November 2019
Compliance with Ethical Standards
:
: This work was supported by Theravance Biopharma R&D, Inc. and Cumberland Pharmaceuticals Inc.
: Dr. Bressler has received fees for participating in advisory boards and speaker bureaus for the Theravance Biopharma group of companies. Dr. Hassoun has received fees for participating in advisory boards and speaker bureaus for the Theravance Biopharma group of companies. Dr. Saravolatz has previously received fees for participating in advisory boards and speaker bureaus for the Theravance Biopharma group of companies; and he has received research grants from Theravance Biopharma US, Inc., paid to Saint John Hospital and Medical Center during the course of the study. Dr. Ravenna is an employee of Theravance Biopharma US, Inc., and holds stock in Theravance Biopharma, Inc. Dr. Castaneda-Ruiz and Dr. Barnes are former employees of Theravance Biopharma US, Inc., and hold stock in Theravance Biopharma, Inc.
: Theravance Biopharma, Inc. (and its affiliates) will not be sharing individual de-identified participant data or other relevant study documents.